chr12-22494922-G-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001286176.2(C2CD5):c.1148-1585C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.601 in 151,720 control chromosomes in the GnomAD database, including 31,966 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.60   (  31966   hom.,  cov: 31) 
Consequence
 C2CD5
NM_001286176.2 intron
NM_001286176.2 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.235  
Publications
6 publications found 
Genes affected
 C2CD5  (HGNC:29062):  (C2 calcium dependent domain containing 5) Enables calcium ion binding activity and calcium-dependent phospholipid binding activity. Involved in cellular response to insulin stimulus; intracellular protein transmembrane transport; and positive regulation of transport. Located in several cellular components, including centriolar satellite; cytoplasmic vesicle membrane; and ruffle membrane. [provided by Alliance of Genome Resources, Apr 2022] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.789  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.601  AC: 91156AN: 151602Hom.:  31958  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
91156
AN: 
151602
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.601  AC: 91176AN: 151720Hom.:  31966  Cov.: 31 AF XY:  0.595  AC XY: 44117AN XY: 74152 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
91176
AN: 
151720
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
44117
AN XY: 
74152
show subpopulations 
African (AFR) 
 AF: 
AC: 
11655
AN: 
41370
American (AMR) 
 AF: 
AC: 
9662
AN: 
15222
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2624
AN: 
3464
East Asian (EAS) 
 AF: 
AC: 
274
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
2828
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
7841
AN: 
10542
Middle Eastern (MID) 
 AF: 
AC: 
211
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
53926
AN: 
67838
Other (OTH) 
 AF: 
AC: 
1357
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 1381 
 2761 
 4142 
 5522 
 6903 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 720 
 1440 
 2160 
 2880 
 3600 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1139
AN: 
3454
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.